TWST

34.56

6.09% -2.24

Handel nachbörslich: 34.56

Twist Bioscience Corp (TWST)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$36.80

Offen:

$36

24-Stunden-Volumen:

1.39M

Relative Volume:

1.28

Marktkapitalisierung:

$2.38B

Einnahmen:

$277.49M

Nettoeinkommen (Verlust:

$-192.14M

KGV:

-10.29

EPS:

-3.36

Netto-Cashflow:

$-95.52M

1W Leistung:

-13.21%

1M Leistung:

-19.42%

6M Leistung:

-23.79%

1J Leistung:

+23.65%

1-Tages-Spanne:

$33.71

$36.54

1-Wochen-Bereich:

$33.71

$40.85

52-Wochen-Spanne:

$27.96

$60.90

Twist Bioscience Corp Stock (TWST) Company Profile

Firmenname

Twist Bioscience Corp

Sektor

Healthcare (1155)

Branche

Diagnostics & Research (59)

Telefon

800-719-0671

Adresse

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Mitarbeiter

923

Twitter

@TwistBioscience

Nächster Verdiensttermin

2025-02-03

Neueste SEC-Einreichungen

TWST's Discussions on Twitter

Vergleichen Sie TWST mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TWST Twist Bioscience Corp	34.56	2.38B	277.49M	-192.14M	-95.52M	-3.36
TMO Thermo Fisher Scientific Inc	421.85	169.62B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	184.96	138.06B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	406.65	32.79B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	100.26	29.99B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	141.22	26.61B	15.41B	1.37B	2.11B	7.50

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-13	Eingeleitet	Wolfe Research	Outperform
2024-06-04	Eingeleitet	Guggenheim	Buy
2024-01-17	Hochstufung	Goldman	Neutral → Buy
2023-09-27	Eingeleitet	Berenberg	Buy
2023-01-05	Eingeleitet	Scotiabank	Sector Outperform
2023-01-03	Hochstufung	Evercore ISI	In-line → Outperform
2022-03-02	Fortgesetzt	Cowen	Outperform
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-06-29	Eingeleitet	William Blair	Outperform
2021-06-04	Eingeleitet	Goldman	Neutral
2021-04-12	Eingeleitet	Piper Sandler	Overweight
2021-02-05	Herabstufung	JP Morgan	Neutral → Underweight
2021-01-04	Herabstufung	Evercore ISI	Outperform → In-line
2020-10-20	Eingeleitet	SVB Leerink	Mkt Perform
2019-05-31	Eingeleitet	Evercore ISI	Outperform
2018-11-26	Eingeleitet	JP Morgan	Neutral

Alle ansehen

Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten

Apr 19, 2025

Is Twist Bioscience Corp (NASDAQ: TWST) A Good Pick For New Investors Now? - Stocksregister

Apr 19, 2025

Apr 16, 2025

Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Alliancebernstein L.P. - Defense World

Apr 16, 2025

Apr 15, 2025

TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com

Apr 15, 2025

LPL Financial LLC Has $2.32 Million Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World

Apr 15, 2025

Apr 14, 2025

Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025 - Business Wire

Apr 14, 2025

Apr 12, 2025

Barclays Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price - Defense World

Apr 12, 2025

Apr 11, 2025

Twist Bioscience CFO Sells Shares to Cover Tax Obligations - TradingView

Apr 11, 2025

Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts - GlobeNewswire Inc.

Apr 11, 2025

Twist Bioscience (NASDAQ:TWST) Trading Down 12.1% After Analyst Downgrade - Defense World

Apr 11, 2025

Apr 05, 2025

Twist Bioscience president sells $7,978 in stock - Investing.com Australia

Apr 05, 2025

Twist Bioscience’s chief legal officer sells shares for $4,802 - Investing.com Australia

Apr 05, 2025

Twist Bioscience’s chief legal officer sells shares for $4,802 By Investing.com - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

Twist Bioscience president sells $7,978 in stock By Investing.com - Investing.com Canada

Apr 04, 2025

Twist Bioscience CEO Sells Shares to Cover Tax Obligations - TradingView

Apr 04, 2025

Apr 03, 2025

KLP Kapitalforvaltning AS Takes Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World

Apr 03, 2025

Mar 31, 2025

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics - Business Wire

Mar 31, 2025

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance

Mar 31, 2025

Mar 28, 2025

Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) CEO Sells 1,726 Shares of Stock - MarketBeat

Mar 28, 2025

Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance

Mar 28, 2025

Mar 25, 2025

Twist Bioscience’s SVP of human resources sells $12,127 in stock - Investing.com India

Mar 25, 2025

Mar 24, 2025

Twist Bioscience CEO Emily Leproust sells $71,932 in shares By Investing.com - Investing.com South Africa

Mar 24, 2025

Twist Bioscience CEO Emily Leproust sells $71,932 in shares - Investing.com India

Mar 24, 2025

Twist Bioscience’s Dennis Cho sells $9,585 in common stock By Investing.com - Investing.com Canada

Mar 24, 2025

Twist Bioscience’s SVP of human resources sells $12,127 in stock By Investing.com - Investing.com Australia

Mar 24, 2025

Twist Bioscience’s Dennis Cho sells $9,585 in common stock - Investing.com

Mar 24, 2025

Mar 20, 2025